Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Warminster, PA
SEC filing record 1 source field available
Fiscal year end
31 December
Arbutus Biopharma Corp has filed 1,026 SEC EDGAR filings since 30 Sep 2008

SEC filing history

Showing 501-525 of 1,000 matching filings.

Per page
25
Current page
21
SC 13D/A File 005-85963

SC 13D/A filing

Filing date
17 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
17 Oct 2017
Reporting date
16 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
17 Oct 2017
Reporting date
16 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-85963

SC 13D/A

Filing date
17 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
17 Oct 2017
Reporting date
16 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
17 Oct 2017
Reporting date
16 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-85963

SC 13D/A

Filing date
17 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-85963

SC 13D/A

Filing date
17 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
17 Oct 2017
Reporting date
16 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34949

FORM 8-K

Filing date
10 Oct 2017
Reporting date
10 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Oct 2017
Reporting date
03 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34949

8-K

Filing date
03 Oct 2017
Reporting date
02 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-34949

8-K

Filing date
03 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-85963

SC 13D/A

Filing date
03 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34949

FORM 8-K

Filing date
03 Oct 2017
Reporting date
03 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34949

FORM 8-K

Filing date
25 Sep 2017
Reporting date
25 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34949

FORM 8-K

Filing date
25 Sep 2017
Reporting date
25 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34949

FORM 8-K

Filing date
22 Sep 2017
Reporting date
22 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34949

FORM 8-K

Filing date
20 Sep 2017
Reporting date
20 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-85963

SC 13D

Filing date
15 Sep 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
14 Sep 2017
Reporting date
06 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34949

FORM 8-K

Filing date
07 Sep 2017
Reporting date
07 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Aug 2017
Reporting date
15 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34949

FORM 8-K

Filing date
14 Aug 2017
Reporting date
14 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-34949

10-Q Q2 2017 ARBUTUS BIOPHARMA

Filing date
03 Aug 2017
Reporting date
30 Jun 2017
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .